Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neuraminidase expressing virus-like particle vaccine provides effective cross protection against influenza virus
Ki‐Hye Kim, Young‐Tae Lee, Soojin Park, et al.
Virology (2019) Vol. 535, pp. 179-188
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Virus-Like Particles: Revolutionary Platforms for Developing Vaccines Against Emerging Infectious Diseases
Hasnat Tariq, Sannia Batool, Saaim Asif, et al.
Frontiers in Microbiology (2022) Vol. 12
Open Access | Times Cited: 143
Advances in Development and Application of Influenza Vaccines
Jidang Chen, Jiehuang Wang, Jipei Zhang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 73
Influenza and Universal Vaccine Research in China
Jiali Li, Yifan Zhang, Xinglong Zhang, et al.
Viruses (2022) Vol. 15, Iss. 1, pp. 116-116
Open Access | Times Cited: 38
Virus-like Particles as Antiviral Vaccine: Mechanism, Design, and Application
Lei Zhang, Wenyue Xu, Xi Ma, et al.
Biotechnology and Bioprocess Engineering (2023) Vol. 28, Iss. 1, pp. 1-16
Open Access | Times Cited: 26
The Quest for a Truly Universal Influenza Vaccine
Yo Han Jang, Baik Lin Seong
Frontiers in Cellular and Infection Microbiology (2019) Vol. 9
Open Access | Times Cited: 67
Broadly Protective Strategies Against Influenza Viruses: Universal Vaccines and Therapeutics
O. A. Vogel, Balaji Manicassamy
Frontiers in Microbiology (2020) Vol. 11
Open Access | Times Cited: 53
Influenza Neuraminidase Characteristics and Potential as a Vaccine Target
Sarah Creytens, Mirte N. Pascha, Marlies Ballegeer, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 51
A mosaic influenza virus-like particles vaccine provides broad humoral and cellular immune responses against influenza A viruses
Xuejie Liu, Tianyi Zhao, Liangliang Wang, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 18
Adjuvanted nanoliposomes displaying six hemagglutinins and neuraminidases as an influenza virus vaccine
Zachary R. Sia, Jayishnu Roy, Wei‐Chiao Huang, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 3, pp. 101433-101433
Open Access | Times Cited: 6
Administration of antigenically distinct influenza viral particle combinations as an influenza vaccine strategy
Xinyu Zhu, Zhaochen Luo, Rebecca Léonard, et al.
PLoS Pathogens (2025) Vol. 21, Iss. 1, pp. e1012878-e1012878
Open Access
Development and evaluation of mosaic VLPs vaccine for enhanced broad-Spectrum immunity against influenza B virus lineages in mice
Tianyi Zhao, Xuejie Liu, Xiaoping Huang, et al.
Vaccine (2025) Vol. 51, pp. 126882-126882
Open Access
Advancements in the conservation of the conformational epitope of membrane protein immunogens
Aisha Mahboob, Nishat Fatma, Faraz Ahmed, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Mixed Plant Viral Infections: Complementation, Interference and Their Effects, a Review
Mónica Roció Sánchez-Tovar, Rafael F. Rivera-Bustamante, Diana L. Saavedra-Trejo, et al.
Agronomy (2025) Vol. 15, Iss. 3, pp. 620-620
Open Access
Influenza Neuraminidase: A Neglected Protein and Its Potential for a Better Influenza Vaccine
Luca T. Giurgea, David M. Morens, Jeffery K. Taubenberger, et al.
Vaccines (2020) Vol. 8, Iss. 3, pp. 409-409
Open Access | Times Cited: 47
Universal protection against influenza viruses by multi-subtype neuraminidase and M2 ectodomain virus-like particle
Ki‐Hye Kim, Zhuo Li, Noopur Bhatnagar, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 8, pp. e1010755-e1010755
Open Access | Times Cited: 22
Progress in the Development of Universal Influenza Vaccines
Wenqiang Sun, Tingrong Luo, Wenjun Liu, et al.
Viruses (2020) Vol. 12, Iss. 9, pp. 1033-1033
Open Access | Times Cited: 36
Influenza vaccine: progress in a vaccine that elicits a broad immune response
Irina Isakova–Sivak, Ekaterina Stepanova, Daria Mezhenskaya, et al.
Expert Review of Vaccines (2021) Vol. 20, Iss. 9, pp. 1097-1112
Closed Access | Times Cited: 29
Respiratory Viruses and Virus-like Particle Vaccine Development: How Far Have We Advanced?
Ki‐Back Chu, Fu‐Shi Quan
Viruses (2023) Vol. 15, Iss. 2, pp. 392-392
Open Access | Times Cited: 11
Recent Progress in Recombinant Influenza Vaccine Development Toward Heterosubtypic Immune Response
Mark B. Carascal, Rance Derrick N. Pavon, Windell L. Rivera
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 17
The Potential of Neuraminidase as an Antigen for Nasal Vaccines To Increase Cross-Protection against Influenza Viruses
Atsushi Kawai, Yasuyuki Yamamoto, Takuto Nogimori, et al.
Journal of Virology (2021) Vol. 95, Iss. 20
Open Access | Times Cited: 22
The Human Antibody Response to the Influenza Virus Neuraminidase Following Infection or Vaccination
Madhusudan Rajendran, Florian Krammer, Meagan McMahon
Vaccines (2021) Vol. 9, Iss. 8, pp. 846-846
Open Access | Times Cited: 22
Neuraminidase delivered as an APC-targeted DNA vaccine induces protective antibodies against influenza
Ina Charlotta Werninghaus, Daniëla Maria Hinke, Even Fossum, et al.
Molecular Therapy (2023) Vol. 31, Iss. 7, pp. 2188-2205
Open Access | Times Cited: 8
A Comparison of Etiology, Pathogenesis, Vaccinal and Antiviral Drug Development between Influenza and COVID-19
Junhao Luo, Zhuohan Zhang, Zhao Song, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6369-6369
Open Access | Times Cited: 8
Pharmacoinformatics and Breed-Based De Novo Hybridization Studies to Develop New Neuraminidase Inhibitors as Potential Anti-Influenza Agents
Lotfi Bourougaa, Mebarka Ouassaf, Bader Y. Alhatlani, et al.
Molecules (2023) Vol. 28, Iss. 18, pp. 6678-6678
Open Access | Times Cited: 8
Supplementation of seasonal vaccine with multi-subtype neuraminidase and M2 ectodomain virus-like particle improves protection against homologous and heterologous influenza viruses in aged mice
Jannatul Ruhan Raha, Ki‐Hye Kim, Noopur Bhatnagar, et al.
Antiviral Research (2024) Vol. 225, pp. 105877-105877
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top